These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6112981)

  • 1. Calcium antagonists: definition and mode of action.
    Nayler WG; Poole-Wilson P
    Basic Res Cardiol; 1981; 76(1):1-15. PubMed ID: 6112981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of action of calcium antagonists.
    Andersson KE; Högestätt ED
    Acta Med Scand Suppl; 1984; 681():11-24. PubMed ID: 6328899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.
    Hattori Y; Hazama S; Kanno M; Nakao Y
    Br J Pharmacol; 1986 Feb; 87(2):299-305. PubMed ID: 2420406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.
    Tappia PS; Okumura K; Kawabata K; Shah KR; Nijjar MS; Panagia V; Dhalla NS
    Mol Cell Biochem; 2001 May; 221(1-2):89-98. PubMed ID: 11506191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium blocking agents. New directions in the treatment of angina pectoris.
    Temkin LP
    Ariz Med; 1980 May; 37(5):328-33. PubMed ID: 6104480
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials.
    Nabata H
    Jpn J Pharmacol; 1977 Apr; 27(2):239-49. PubMed ID: 886659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.
    Lee KS; Tsien RW
    Nature; 1983 Apr; 302(5911):790-4. PubMed ID: 6302512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonistic drugs. Mechanism of action.
    Church J; Zsotér TT
    Can J Physiol Pharmacol; 1980 Mar; 58(3):254-64. PubMed ID: 7378928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists. Pharmacodynamic effects and mechanism of action.
    Zsotér TT; Church JG
    Drugs; 1983 Feb; 25(2):93-112. PubMed ID: 6131809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.